Larimar Therapeutics, Inc.

Bank of New York Mellon Corp LRMR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

115,928

Value ($000)

442

Weight

0.0%

2021 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	442	0.0%	115,928	12/31/2025
2025 Q3	11/3/2025	359	0.0%	111,040	9/30/2025
2025 Q2	8/5/2025	289	0.0%	99,889	6/30/2025
2025 Q1	4/29/2025	216	0.0%	100,453	3/31/2025
2024 Q4	2/4/2025	389	0.0%	100,453	12/31/2024
2024 Q3	11/12/2024	646	0.0%	98,630	9/30/2024
2024 Q2	7/25/2024	978	0.0%	134,877	6/30/2024
2024 Q1	4/25/2024	651	0.0%	85,775	3/31/2024
2023 Q4	1/29/2024	440	0.0%	96,764	12/31/2023
2023 Q3	10/24/2023	386	0.0%	97,838	9/30/2023
2023 Q2	8/3/2023	306	0.0%	97,838	6/30/2023
2023 Q1	5/9/2023	131	0.0%	28,817	3/31/2023
2022 Q4	2/14/2023	119	0.0%	28,817	12/31/2022
2022 Q3	11/14/2022	60	0.0%	18,973	9/30/2022
2022 Q2	8/15/2022	37	0.0%	18,973	6/30/2022
2022 Q1	5/11/2022	77	0.0%	18,973	3/31/2022
2021 Q4	2/11/2022	205	0.0%	18,973	12/31/2021
2021 Q3	11/18/2021	219	0.0%	18,973	9/30/2021
2021 Q2	8/11/2021	187	0.0%	18,973	6/30/2021
2021 Q1	5/13/2021	277	0.0%	18,973	3/31/2021